SEC Form 4 · accession 0001535610-18-000070
Rosetta Genomics Ltd. · ROSG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Mar 16, 2018
Accepted (ET)
Mar 19, 2018 · 9:40 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362959
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ADR Shares (each one equal to 2 ordinary shares)F1,F2 | Mar 16, 2018 | P | 1,400 | $0.4211 | A | 871,710 | I | See Footnotes |
| ADR Shares (each one equal to 2 ordinary shares)F1,F2 | Mar 16, 2018 | P | 20,229 | $0.4261 | A | 891,939 | I | See Footnotes |
| ADR Shares (each one equal to 2 ordinary shares)F1,F2 | Mar 16, 2018 | P | 9,247 | $0.4294 | A | 901,186 | I | See Footnotes |
| ADR Shares (each one equal to 2 ordinary shares)F1,F2 | Mar 16, 2018 | P | 33,413 | $0.4353 | A | 934,599 | I | See Footnotes |
| ADR Shares (each one equal to 2 ordinary shares)F1,F2 | Mar 16, 2018 | P | 9 | $0.4201 | A | 934,608 | I | See Footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is manager of Advisor.
- F2The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.